Biodesix Inc. (BDSX): Price and Financial Metrics
BDSX Price/Volume Stats
| Current price | $1.57 | 52-week high | $2.21 |
| Prev. close | $1.36 | 52-week low | $1.11 |
| Day low | $1.32 | Volume | 752,500 |
| Day high | $1.61 | Avg. volume | 213,925 |
| 50-day MA | $1.43 | Dividend yield | N/A |
| 200-day MA | $1.53 | Market Cap | 228.38M |
BDSX Stock Price Chart Interactive Chart >
Biodesix Inc. (BDSX) Company Bio
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.
BDSX Price Returns
| 1-mo | 30.83% |
| 3-mo | -12.78% |
| 6-mo | -4.85% |
| 1-year | -9.25% |
| 3-year | -62.80% |
| 5-year | N/A |
| YTD | -14.67% |
| 2023 | -20.00% |
| 2022 | -56.52% |
| 2021 | -73.76% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...